Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs.

Kalra, Sunishtha, Malik, Rohit, Singh, Govind , Bhatia, Saurabh, Al-Harrasi, Ahmed, Mohan, Syam, Albratty, Mohammed, Albarrati, Ali and Tambuwala, Murtaza (2022) Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs. Inflammopharmacology, 30 (4). pp. 1153-1166. ISSN 0925-4692

Full content URL: https://doi.org/10.1007/s10787-022-01017-8

Documents
Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs
Published Open Access manuscript
[img]
[Download]
[img]
Preview
PDF
s10787-022-01017-8.pdf - Whole Document
Available under License Creative Commons Attribution 4.0 International.

1MB
Item Type:Article
Item Status:Live Archive

Abstract

Traumatic brain injury (TBI) is an important global health concern that represents a leading cause of death and disability. It occurs due to direct impact or hit on the head caused by factors such as motor vehicles, crushes, and assaults. During the past decade, an abundance of new evidence highlighted the importance of inflammation in the secondary damage response that contributes to neurodegenerative and neurological deficits after TBI. It results in disruption of the blood-brain barrier (BBB) and initiates the release of macrophages, neutrophils, and lymphocytes at the injury site. A growing number of researchers have discovered various signalling pathways associated with the initiation and progression of inflammation. Targeting different signalling pathways (NF-κB, JAK/STAT, MAPKs, PI3K/Akt/mTOR, GSK-3, Nrf2, RhoGTPase, TGF-β1, and NLRP3) helps in the development of novel anti-inflammatory drugs in the management of TBI. Several synthetic and herbal drugs with both anti-inflammatory and neuroprotective potential showed effective results. This review summarizes different signalling pathways, associated pathologies, inflammatory mediators, pharmacological potential, current status, and challenges with anti-inflammatory drugs.

Keywords:Anti-inflammatory drugs; Clinical trial; Management; Neuroinflammation; Pathogenesis; Traumatic brain injury
Subjects:A Medicine and Dentistry > A100 Pre-clinical Medicine
A Medicine and Dentistry > A300 Clinical Medicine
Divisions:College of Science > Lincoln Medical School
Related URLs:
ID Code:51718
Deposited On:15 Sep 2022 14:40

Repository Staff Only: item control page